Efficacy and Safety of GLPG0634 in Subjects With Active Crohn's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

175

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

February 29, 2016

Conditions
Crohn's Disease
Interventions
DRUG

GLPG0634

100 mg oral tablet, intake once daily for 20 weeks

DRUG

Placebo

placebo oral tablets, intake once daily for 20 weeks

Trial Locations (63)

Unknown

St. Pierre University Hospital Center, Brussels

University Hospital Saint Luc, Brussels

University Hospital Ghent, Ghent

University Hospitals Leuven, Leuven

CHR de la Citadelle, Liège

Clinic Saint Joseph, Liège

Hepato-Gastroenterology HK Ltd., Hradec Králové

University Hospital Olomouc, Olomouc

Outpatient Clinic of Internal Medicine and Gastroenterology, Pilsen

Institute of Clinical and Experimental Medicine, Prague

Masaryk's Hospital Usti Nad Labem, Ústí nad Labem

Hospital Znojmo, Znojmo

Hospital Gabriel Montpied, Clermont-Ferrand

Beaujon Hospital, Clichy

Dijon University Hospital Center, Dijon

Hospital Michallon, Grenoble

Lille Regional University Hospital Center, Lille

North Hospital, Marseille

Archet Hospital, Nice

Saint Etienne University Hospital Center, Saint-Etienne

DRK Clinics Berlin Westend, Berlin

Interdisciplinary Crohn Colitis Center Rhein Main, Frankfurt am Main

Asklepios West Hospital Hamburg, Hamburg

University Hospital Jena, Jena

University Hospital Schleswig-Holstein, Kiel

University Hospital Magdeburg, Magdeburg

Gastroenterology Group Practice Minden, Minden

Internal Medicine Group Practice Oldenburg, Oldenburg

Drug Research Center Ltd., Balatonfüred

Clinexpert Medical Center, Budapest

Semmelweis University, Budapest

Szent Margit Hospital, Budapest

University of Debrecen, Medical and Health Science Center, Debrecen

Bekes County Pandy Kalman Hospital, Gyula

Tolna County Balassa Janos Hospital, Szekszárd

Jan Biziel University Hospital #2, Bydgoszcz

Saint Family Hospital Medical Center, Lodz

H-T. Medical Center, Tychy

Clinical Hospital of Ministry of Internal Affairs and Administration, Warsaw

Maternal, Pediatric and Adolescent Healtcare Centre, Gastroenterology Diagnostic Facility for Adults, Warsaw

Vivamed, Warsaw

Active Health Center, Wroclaw

Colentina Clinical Hospital, Bucharest

Fundeni Clinical Institute, Bucharest

Medical Center for Gastroenterology, Cluj-Napoca

Center for Gastroenterology, Ltd, Timișoara

Territorial Clinical Hospital, Barnaul

State Medical University, Kazan'

Territorial Clinical Hospital, Krasnoyarsk

A.N. Ryzhikh State Research Center for Coloproctology, Moscow

City Clinical Hospital #24, Moscow

Moscow Clinical Research Center, Moscow

Vladimirsky Regional Clinical Research Institute, Moscow

Semashko Nizhny Novgorod Regional Clinical Hospital, Nizhny Novgorod

City Clinical Hospital #12, Novosibirsk

City Clinical Hospital #31, Saint Petersburg

First Pavlov State Medical University, Saint Petersburg

Mechnikov North-Western State Medical University, Saint Petersburg

St. Elizabeth City Hospital, Saint Petersburg

Queen Elizabeth Hospital, Birmingham

Royal Bournemouth Hospital, Bournemouth

St Mark's Hospital, Harrow

Manchester Royal Infirmary, Manchester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Galapagos NV

INDUSTRY